Abstract:Genetic engineering, which was first developed in the 1980s, allows for specific additions to animals’ genomes that are not possible through conventional breeding. Using genetic engineering to improve agricultural animals was first suggested when the technology was in the early stages of development by Palmiter et al. (Nature 300:611–615, 1982). One of the first agricultural applications identified was generating transgenic dairy animals that could produce altered or novel proteins in their milk. Human milk contains high levels of antimicrobial proteins that are found in low concentrations in the milk of ruminants, including the antimicrobial proteins lactoferrin and lysozyme. Lactoferrin and lysozyme are both part of the innate immune system and are secreted in tears, mucus, and throughout the gastrointestinal (GI) tract. Due to their antimicrobial properties and abundance in human milk, multiple lines of transgenic dairy animals that produce either human lactoferrin or human lysozyme have been developed. The focus of this review is to catalogue the different lines of genetically engineered dairy animals that produce either recombinant lactoferrin or lysozyme that have been generated over the years as well as compare the wealth of research that has been done on the in vitro and in vivo effects of the milk they produce. While recent advances including the development of CRISPRs and TALENs have removed many of the technical barriers to predictable and efficient genetic engineering in agricultural species, there are still many political and regulatory hurdles before genetic engineering can be used in agriculture. It is important to consider the substantial amount of work that has been done thus far on well established lines of genetically engineered animals evaluating both the animals themselves and the products they yield to identify the most effective path forward for future research and acceptance of this technology.

Research Progress on the Production of Recombinant Human Lysozyme in Transgenic Animal

Production of Transgenic-Cloned Pigs Expressing Large Quantities of Recombinant Human Lysozyme in Milk

Construction and in vivo evaluation of a mammary gland-specific expression vector for human lysozyme

Production of human lactoferrin and lysozyme in the milk of transgenic dairy animals: past, present, and future

Expression of Recombinant Porcine Lactoferrin N-lobe in Pichia Methanolica and Its Antibacterial Activity

The Expression of Recombinant Human Serum Albumin in the Mammary Gland of Transgenic Mice

Expression of Recombinant Human Lysozyme in Egg Whites of Transgenic Hens

Purification and Characterization of Recombinant Human Lysozyme from Eggs of Transgenic Chickens

[Transgenic Animals Bioreactors].

The molecular modification, expression, and the antibacterial effects studies of human lysozyme

Expression Systems and Species Used for Transgenic Animal Bioreactors

Efficient Production of Human Goose-Type Lysozyme 2 in the Methylotrophic Yeast Pichia Pastoris.

Expression of a Recombinant Anti-Programed Cell Death 1 Antibody in the Mammary Gland of Transgenic Mice

Advances in microbial antimicrobial peptides expression system and transformation strategy

Advances in Research of Silk Gland Bioreactor of piggyBac-Mediated Transgenic Silkworm

Research Progress on the Production of Lycopene by Recombinant Escherichia Coli

Cytokinetic engineering enhances the secretory production of recombinant human lysozyme in Komagataella phaffii

Progress in the Production of Human Antibodies from Transgenic Mice and Transchromosomic Mice

A Study on the Expression of Recombinant Human Lysozyme in Pichia Pastoris

Expression of Recombinant Human Lysozyme in Transgenic Chicken Promotes the Growth of Bifidobacterium in the Intestine and Improves Postnatal Growth of Chicken

Recent Insights Into the Prognostic and Therapeutic Applications of Lysozymes